Imidazole Propionate is Increased in Diabetes and Associated with Stool Consistency

References

• Pedersen HK, Gudmundsdottir V, Nielsen HB, et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature. 2016;535(7612):376–381. doi:10.1038/nature18646
   PubMed Web of Science ®Google Scholar
• Jia W, Wei M, Rajani C, Zheng X. Targeting the alternative bile acid synthetic pathway for metabolic diseases. Protein Cell. 2020. doi:10.1007/s13238-020-00804-9
   Web of Science ®Google Scholar
• Burton JH, Johnson M, Johnson J, Hsia DS, Greenway FL, Heiman ML. Addition of a gastrointestinal microbiome modulator to metformin improves metformin tolerance and fasting glucose levels. J Diabetes Sci Technol. 2015;9(4):808–814. doi:10.1177/1932296815577425
   PubMedGoogle Scholar
• Bogachev AV, Bertsova YV, Bloch DA, Verkhovsky MI. Urocanate reductase: identification of a novel anaerobic respiratory pathway in Shewanella oneidensis MR-1. Mol Microbiol. 2012;86(6):1452–1463. doi:10.1111/mmi.12067
   Web of Science ®Google Scholar
• Koh A, Molinaro A, Stahlman M, et al. Microbially produced imidazole propionate impairs insulin signaling through mTORC1. Cell. 2018;175(4):947–61 e17. doi:10.1016/j.cell.2018.09.055
   PubMed Web of Science ®Google Scholar
• Koh A, Manneras-Holm L, Yunn NO, et al. Microbial imidazole propionate affects responses to metformin through p38gamma-dependent inhibitory AMPK phosphorylation. Cell Metab. 2020;32(4):643–53e4. doi:10.1016/j.cmet.2020.07.012
   Web of Science ®Google Scholar
• Cani PD. Microbiota and metabolites in metabolic diseases. Nat Rev Endocrinol. 2019;15(2):69–70. doi:10.1038/s41574-018-0143-9
   PubMed Web of Science ®Google Scholar
• Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;19(1):55–71. doi:10.1038/s41579-020-0433-9
   PubMed Web of Science ®Google Scholar
• Wu H, Tremaroli V, Schmidt C, et al. The gut microbiota in prediabetes and diabetes: a population-based cross-sectional study. Cell Metab. 2020;32(3):379–90 e3. doi:10.1016/j.cmet.2020.06.011
   PubMed Web of Science ®Google Scholar
• Molinaro A, Bel Lassen P, Henricsson M, et al. Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology. Nat Commun. 2020;11(1):5881. doi:10.1038/s41467-020-19589-w
   PubMed Web of Science ®Google Scholar
• Van der Heiden C, Wadman SK, de Bree PK, Wauters EA. Increased urinary imidazolepropionic acid, N-acetylhistamine and other imid azole compounds in patients with intestinal disorders. Clin Chim. 1972;39(1):201–214. doi:10.1016/0009-8981(72)90317-8
   Web of Science ®Google Scholar
• Yamamoto M, Pinto-Sanchez MI, Bercik P, Britz-McKibbin P. Metabolomics reveals elevated urinary excretion of collagen degradation and epithelial cell turnover products in irritable bowel syndrome patients. Metabolomics. 2019;15(6):82. doi:10.1007/s11306-019-1543-0
   Web of Science ®Google Scholar
• Vandeputte D, Falony G, Vieira-Silva S, Tito RY, Joossens M, Raes J. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut. 2016;65(1):57–62. doi:10.1136/gutjnl-2015-309618
   PubMed Web of Science ®Google Scholar
• Yap CX, Henders AK, Alvares GA, et al. Autism-related dietary preferences mediate autism-gut microbiome associations. Cell. 2021;184(24):5916–31 e17. doi:10.1016/j.cell.2021.10.015
   PubMed Web of Science ®Google Scholar
• Bunnett NW. Neuro-humoral signalling by bile acids and the TGR5 receptor in the gastrointestinal tract. J Physiol. 2014;592(14):2943–2950. doi:10.1113/jphysiol.2014.271155
   PubMed Web of Science ®Google Scholar
• Alemi F, Poole DP, Chiu J, et al. The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice. Gastroenterology. 2013;144(1):145–154. doi:10.1053/j.gastro.2012.09.055
   PubMed Web of Science ®Google Scholar
• Vijayvargiya P, Camilleri M, Burton D, Busciglio I, Lueke A, Donato LJ. Bile and fat excretion are biomarkers of clinically significant diarrhoea and constipation in irritable bowel syndrome. Aliment Pharmacol Ther. 2019;49(6):744–758. doi:10.1111/apt.15106
   PubMed Web of Science ®Google Scholar
• Vuong HE, Pronovost GN, Williams DW, et al. The maternal microbiome modulates fetal neurodevelopment in mice. Nature. 2020;586(7828):281–286. doi:10.1038/s41586-020-2745-3
   PubMed Web of Science ®Google Scholar
• Tanes C, Bittinger K, Gao Y, et al. Role of dietary fiber in the recovery of the human gut microbiome and its metabolome. Cell Host Microbe. 2021;29(3):394–407 e5. doi:10.1016/j.chom.2020.12.012
   PubMed Web of Science ®Google Scholar
• Chen PB, Black AS, Sobel AL, et al. Directed remodeling of the mouse gut microbiome inhibits the development of atherosclerosis. Nat Biotechnol. 2020;38(11):1288–1297. doi:10.1038/s41587-020-0549-5
   PubMed Web of Science ®Google Scholar
• Camilleri M, Vijayvargiya P. The role of bile acids in chronic diarrhea. Am J Gastroenterol. 2020;115(10):1596–1603. doi:10.14309/ajg.0000000000000696
   PubMed Web of Science ®Google Scholar
• Misawa N, Higurashi T, Takatsu T, et al. The benefit of elobixibat in chronic constipation is associated with faecal deoxycholic acid but not effects of altered microbiota. Aliment Pharmacol Ther. 2020;52(5):821–828. doi:10.1111/apt.15950
   PubMed Web of Science ®Google Scholar
• Von Schwartzenberg RJ, Bisanz JE, Lyalina S, et al. Caloric restriction disrupts the microbiota and colonization resistance. Nature. 2021;595(7866):272–277. doi:10.1038/s41586-021-03663-4
   PubMed Web of Science ®Google Scholar
• Tian Y, Gui W, Koo I, et al. The microbiome modulating activity of bile acids. Gut Microbes. 2020;11(4):979–996. doi:10.1080/19490976.2020.1732268
   PubMed Web of Science ®Google Scholar
• Wang L, Gong Z, Zhang X, et al. Gut microbial bile acid metabolite skews macrophage polarization and contributes to high-fat diet-induced colonic inflammation. Gut Microbes. 2020;12(1):1–20. doi:10.1080/19490976.2020.1819155
   Web of Science ®Google Scholar
• Wang S, Martins R, Sullivan MC, et al. Diet-induced remission in chronic enteropathy is associated with altered microbial community structure and synthesis of secondary bile acids. Microbiome. 2019;7(1). doi:10.1186/s40168-019-0740-4
   Web of Science ®Google Scholar
• Worthmann A, John C, Ruhlemann MC, et al. Cold-induced conversion of cholesterol to bile acids in mice shapes the gut microbiome and promotes adaptive thermogenesis. Nat Med. 2017;23(7):839–849. doi:10.1038/nm.4357
   Web of Science ®Google Scholar
• Van Best N, Rolle-Kampczyk U, Schaap FG, et al. Bile acids drive the newborn’s gut microbiota maturation. Nat Commun. 2020;11(1):3692. doi:10.1038/s41467-020-17183-8
   PubMed Web of Science ®Google Scholar
• Hornef ARKHAWNBM, Hassani K, Walker A. Disturbed gut microbiota and bile homeostasis in Giardia -infected mice contributes to metabolic dysregulation and growth impairment. Sci Transl Med. 2020;12(565):7019. doi:10.1126/scitranslmed.aay7019
   Web of Science ®Google Scholar
• Hibberd AA, Yde CC, Ziegler ML, et al. Probiotic or synbiotic alters the gut microbiota and metabolism in a randomised controlled trial of weight management in overweight adults. Benef Microbes. 2019;10(2):121–135. doi:10.3920/BM2018.0028
   PubMed Web of Science ®Google Scholar
• Allada R, Bass J, Longo DL. Circadian mechanisms in medicine. N Engl J Med. 2021;384(6):550–561. doi:10.1056/NEJMra1802337
   PubMed Web of Science ®Google Scholar
• Wilmanski T, Rappaport N, Earls JC, et al. Blood metabolome predicts gut microbiome alpha-diversity in humans. Nat Biotechnol. 2019;37(10):1217–1228. doi:10.1038/s41587-019-0233-9
   PubMed Web of Science ®Google Scholar
• Ahmed F, Brewington C, Chang KJ, Moreno CC, Gollub M, Yee J. Letter to the editor regarding: multicentre, prospective, randomised study comparing the diagnostic yield of colon capsule endoscopy versus CT colonography in a screening population (the TOPAZ study). Gut. 2022;71(1):214–215. doi:10.1136/gutjnl-2021-324396
   Web of Science ®Google Scholar
• Gram-Kampmann EM, Hansen CD, Hugger MB, et al. Effects of a 6-month, low-carbohydrate diet on glycaemic control, body composition, and cardiovascular risk factors in patients with type 2 diabetes: an open-label randomized controlled trial. Diabetes Obes Metab. 2022;24(4):693–703. doi:10.1111/dom.14633
   Web of Science ®Google Scholar